Inuvo IncINUV
Price$0.58

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $52.3M-37.6% YoYTTM through 30 Jun 2026
Net Income -$4.5MTTM through 30 Jun 2026
Free Cash Flow -$3.6MTTM through 30 Jun 2026

Margins

Current
Gross Margin46.2%
EBITDA Margin-14.6%
Operating Margin-49.0%
Net Margin-8.6%

Returns

-16.0%ROE
8.2%ROA

Balance Sheet Health

Debt / Equity0.26x
Current Ratio0.74x
Net Debt$412.9K
Cash & Equivalents$886.5K

Quality Metrics

Altman Z-Score-8.44
Piotroski F-Score2 / 9
FCF Margin-6.9%
Earnings-Beat Rate100.0%

Multi-Year Trend

Revenue
'24'25
FY2025: $86.2M
Diluted EPS
'19'20'21'22'23'24'25
FY2025: $-0.35

Dividend

No dividend

Capital Allocation

Capex Intensity2.6%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.